Processa Pharmaceuticals
PCSA
PCSA
9 hedge funds and large institutions have $63.2K invested in Processa Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
28% less capital invested
Capital invested by funds: $87.5K → $63.2K (-$24.3K)
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$20.7K | |
| 2 | +$16K | |
| 3 | +$4.6K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $20.7K |
|
|||
|
VF
2
Virtu Financial
New York
| $16K |
|
|||
3
Geode Capital Management
Boston,
Massachusetts
| $12.7K |
|
|||
4
Vanguard Group
Malvern,
Pennsylvania
| $9.04K |
|
|||
|
MMA
5
Miracle Mile Advisors
Los Angeles,
California
| $3.7K |
|
|||
|
TRCT
6
Tower Research Capital (TRC)
New York
| $913 |
|
|||
7
Wells Fargo
San Francisco,
California
| $57 |
|
|||
8
UBS Group
Zurich,
Switzerland
| $21 |
|
|||
|
9
Bank of America
Charlotte,
North Carolina
| $14 |
|
|||
|
HF
10
HRT Financial
New York
| – |
|